Translate Bio: Sanofi to Acquire Translate Bio for $3.2B
Upgrades drug formulation capabilities and accelerates development of licensed programs in vaccines and potential to explore other therapeutic areas.
Read full article »
CEO
Translate Bio is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases.
Read more